Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

712
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
712
One-Way ANOVA01:18

One-Way ANOVA

8.1K
One-way ANOVA analyzes more than three samples categorized by one factor. For example, it can compare the average mileage of sports bikes. Here, the data is categorized by one factor - the company. However, one-way ANOVA cannot be used to simultaneously compare the sample mean of three or more samples categorized by two factors. An example of two factors would be sports bikes from different companies driven in different terrains, such as a desert or snowy landscape. Here, two-way ANOVA is used...
8.1K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

298
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
298
Two-Way ANOVA01:17

Two-Way ANOVA

2.8K
The two-way ANOVA is an extension of the one-way ANOVA. It is a statistical test performed on three or more samples categorized by two factors - a row factor and a column factor. Ronald Fischer mentioned it in 1925 in his book 'Statistical Methods for Researchers.'
The two-way ANOVA analysis initially begins by stating the null hypothesis that there is an interaction effect between the two factors of a dataset. This effect can be visualized using line segments formed by joining the...
2.8K
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

5.9K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
5.9K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.5K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same author

Toward Evidence Synthesis of Adverse Events in Imbalanced Time-to-Event Data.

Journal of evidence-based medicine·2026
Same author

Transcriptomic signatures of synaptic loss in Alzheimer's disease.

iScience·2026
Same author

Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition).

Chinese neurosurgical journal·2026
Same author

Corrigendum to "Multidisciplinary exploration of ancient atherosclerosis: Paleo-genomic and paleo-nutritional analysis of a 13th century artificial mummy in China" [J. Genet. Genom. (2026) 53, 906-918].

Journal of genetics and genomics = Yi chuan xue bao·2026
Same author

Kidney Effects of Finerenone Added to Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease.

Diabetes, obesity & metabolism·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
Same journal

An interpretable XGboost algorithm for predicting 30-day mortality in acute pancreatitis using routine biomarkers.

BMC medical research methodology·2026
查看所有相关文章

相关实验视频

Updated: Sep 12, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.7K

在组件网络元分析中,用于贡献分析的留出一个漏出算法.

Yunhe Mao1,2, Yiwen Shen3, Qinbo Yang4

  • 1Sports Medicine Center, West China Hospital, Sichuan University, Chengdu, China.

BMC medical research methodology
|August 8, 2025
PubMed
概括
此摘要是机器生成的。

一个新的"离开"算法量化了组件网络元分析 (CNMA) 中的证据贡献. 该方法通过识别关键数据源,提高了复杂干预效应的可解释性.

关键词:
组件网络的元分析.贡献 贡献 贡献 贡献证据综合研究

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
08:33

Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria

Published on: July 28, 2023

689

相关实验视频

Last Updated: Sep 12, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.7K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
08:33

Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria

Published on: July 28, 2023

689

科学领域:

  • 生物统计学 生物统计学
  • 卫生研究方法论 卫生研究方法论
  • 证据综合 证据综合

背景情况:

  • 组件网络元分析 (CNMA) 允许在多组件治疗中分离单个组件效应.
  • 目前的CNMA方法缺乏确定的方法来量化具体比较对成分效应估计的证据贡献.
  • 这一缺陷阻碍了CNMA结果的解释性和透明度.

研究的目的:

  • 开发和验证一种新的方法,用于量化成分比较对CNMA成分效应估计的贡献.
  • 为了提高复杂干预的证据综合的解释性和精度.

主要方法:

  • 提出了一个留出一个漏洞的算法,代地排除了网络中的每个比较 (边缘).
  • 该算法重新计算组件效应差异,并根据诱导的差异膨胀量化精度杆.
  • 为无法识别的组件制定了特殊规则,该方法将估计分解为直接和添加证据来源.

主要成果:

  • 抛出一个算法成功地通过检测排除时的显著差异变化来识别关键证据来源.
  • 精确杆有效量化了孤立特定组件的比较的重要性.
  • 应用到现实世界的数据证明了该方法在复杂网络中的精度,并与参数分解保持一致.

结论:

  • 抛出一个的算法提供了一个强大的,基于差异的框架来量化CNMA的证据贡献,解决了关键的方法差距.
  • 这种方法可靠地识别关键的证据来源,以确定组件的识别性和精度.
  • 它显著提高了复杂干预的证据综合的透明度和可解释性.